Tradestie Institutional Equity Comparison Engine

NVCT vs ATYR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 1โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure while NVCT counters with relative strength in Growth & Margin. Fundamentally, NVCT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ATYR at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NVCT sits in BREAKDOWN (9th %ile IV; Dealer Gamma Walls on Pro) against ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NVCT N/M vs ATYR N/M Fwd P/E
Growth & Margin Winner NVCT
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner ATYR
1Y +216.8% vs +541.4% ยท 52W Pos 57% vs 60%
Options & Structure Winner ATYR
BREAKDOWN (9th %ile IV) vs UNCLASSIFIED (36th %ile IV)
NVCT NASDAQ
Nuvectis Pharma, Inc. Common Stock
Pharmaceutical Preparations
$19.07
-0.21% 1D
Market Cap $696.0M
1M Return +0.69%
1Y Return +216.78%
Forward P/E N/M
Unified AI Score
53.4 / 100 HOLD
Tech 58.0 Fund 59.0 Flow 66.0 Mom 50.0
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.83
-7.82% 1D
Market Cap $15.6M
1M Return +2713.05%
1Y Return +541.43%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NVCT +216.78% ATYR +541.43% Spread: +324.65 pp (ATYR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NVCT TTM Op. Margin: 0.0% ATYR TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NVCT vs ATYR. Trailing 12-month operating profitability (NVCT 0.0% vs ATYR 0.0%) and valuation multiples (NVCT N/M vs ATYR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NVCT (4) vs ATYR (1)
Institutional Metric NVCT ATYR Criterion Row Winner
Market Capitalization Scale $696.0M $15.6M Larger Scale NVCT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -67.0% -93.7% Higher ROE NVCT
52-Week Range Position Momentum 57% ($6โ€“$29) 60% ($0โ€“$8) Stronger Trend ATYR
Beta / 30D Volatility Risk Regime 0.70ฮฒ ยท 82% Vol -9.57ฮฒ ยท 13806% Vol Lower Realized Risk NVCT
Unified Institutional Score Composite Signal 53.4 / 100 (HOLD) 34.3 / 100 (SELL) Higher Composite NVCT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NVCT vs ATYR Buy Guide
NVCT BREAKDOWN
99d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 9th %ile
IV Regime Compressed (<25th %ile)
Live NVCT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NVCT nor ATYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.